SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan
Journal:
Current Neuropharmacology
Volume:
19
Page:
1019-1037
Author(s):
Priya Mishra, Amit Kumar Mittal, Harikesh Kalonia, Swati Madan, Shampa Ghosh, Jitendra Kumar Sinha* and Satyendra Kumar Rajput*
Recent Patents, Regulatory Issues, and Toxicity of Nanoparticles in Neuronal Disorders
Journal:
Current Drug Metabolism
Volume:
22
Page:
263-279
Author(s):
Abdul Muheem, Mohammed A. Jahangir, Chandra P. Jaiswal, Mohammed Jafar, Mohammad Z. Ahmad, Javed Ahmad and Musarrat H. Warsi*
Nanotechnology Driven Approaches for the Management of Parkinson’s Disease: Current Status and Future Perspectives
Journal:
Current Drug Metabolism
Volume:
22
Page:
287-298
Author(s):
Shrestha Sharma, Syed A. Rabbani*, Tanya Agarwal, Sanjula Baboota, Faheem H. Pottoo and Renu Kadian
Efficacy and Cardiovascular Safety of DPP-4 Inhibitors
Journal:
Current Drug Safety
Volume:
16
Page:
154-164
Author(s):
Nikhila A. Subrahmanyan, Rithika M. Koshy, Koshy Jacob and Joseph M. Pappachan*
Nanomedicine against Alzheimer’s and Parkinson’s Disease
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
1507-1545
Author(s):
Ankit Tandon, Sangh J. Singh and Rajnish K. Chaturvedi*
Targeting COVID-19 in Parkinson’s Patients: Drugs Repurposed
Journal:
Current Medicinal Chemistry
Volume:
28
Page:
2392-2408
Author(s):
Firoz Anwar*, Salma Naqvi, Fahad A. Al-Abbasi, Nauroz Neelofar, Vikas Kumar, Ankit Sahoo and Mohammad Amjad Kamal*
Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry
Journal:
Current Neuropharmacology
Volume:
19
Page:
591-609
Author(s):
H. Fanet, L. Capuron, N. Castanon, F. Calon and S. Vancassel*
Perspectives on Drug Repurposing
Journal:
Current Medicinal Chemistry
Volume:
28
Page:
2085-2099
Author(s):
Alejandro Schcolnik-Cabrera, Daniel Juárez-López and Alfonso Duenas-Gonzalez*
Herbal Resources to Combat a Progressive & Degenerative Nervous System Disorder- Parkinson’s Disease
Journal:
Current Drug Targets
Volume:
22
Page:
609-630
Author(s):
Rajeev K. Singla, Tanya Agarwal, Xuefei He and Bairong Shen*
Implications of VIP and PACAP in Parkinson’s Disease: What do we Know So Far?
Journal:
Current Medicinal Chemistry
Volume:
28
Page:
1703-1715
Author(s):
Filipe Resende Oliveira de Souza, Fabiola Mara Ribeiro* and Patrícia Maria d’Almeida Lima*